It has been argued by others that both m6A and m6Am are targeted by FTO, but FTO’s demethylation of m6A mediates its biologically relevant effects, especially in AML, since FTO directly targets key oncogenic drivers like MYC9,10,60. This evidence concerns the gene FTO and acute myeloid leukemia.